← Back to Patent Explorer
US4438105A Expired / Lapsed US ⏱️ 0.0 years remaining

4'-Iododerivatives of anthracycline glycosides

Assignee: Pfizer Italia SRL
•
Filing: 1982-04-14
•
Granted: 1984-03-20
•
Expires: 2002-04-14
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Starting from the known 4'-deoxy-4'-iodo-N-trifluoroacetyldaunorubicin, two new anthracycline glycosidic antibiotics, the 4'-deoxy-4'-iodo-daunorubicin and 4'-deoxy-4'-iodo-doxorubicin, have been prepared by known procedures. Both the new glycosides have been found to be endowed with outstanding antitumoral activity.

Inventors

  • 👤 Antonino Suarato
  • 👤 Sergio Penco
  • 👤 Federico Arcamone
  • 👤 Anna M. Casazza

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-31 23:34
CPC Classifications
C; C07; C07H; C07H15/00; C07H15/20; C07H15/24; C07H15/252; A; A61; A61P; A61P35/00

Claims Analysis

Total Claims: 6
Claim 1
Independent Claim 20 words
An anthracycline glycosidic compound of the general formula I. ##STR2## wherein R is a hydrogen atom or a hydroxy group.
Claim 2
Dependent Claim 20 words
An anthracycline glycosidic compound of the general formula I. ##STR2## wherein R is a hydrogen atom or a hydroxy group.
Claim 3
Dependent Claim 9 words
A compound according to claim 1, which is 4'-deoxy-4'-iododaunorubicin.
Claim 4
Dependent Claim 9 words
A compound according to claim 1, which is 4'-deoxy-4'-iododoxorubicin.
Claim 5
Dependent Claim 40 words
A pharmaceutical composition having antitumor activity against a tumor selected from the group consisting of P388 leukemia and gross leukemia comprising a therapeutically effective amount of an anthracycline glycoside according to claim 1 in combination with an inert carrier therefor.
Claim 6
Dependent Claim 43 words
A method of inhibiting the growth of a tumor selected from the group of P388 leukemia or Gross leukemia, said method comprising administering to a host afflicted with said tumor a therapeutically effective amount of an anthracycline glycoside as claimed in claim 1.

References Cited (Backward Citations)

US4303785A Cited
US4345070A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1987-03-20 1987-09-19 1988-03-20 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1991-03-20 1991-09-19 1992-03-20 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1995-03-20 1995-09-19 1996-03-20 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag